Jasbir Seehra, CEO of Keros Therapeutics KROS, has filed 0 purchases and 1 sale on the open market. Over the past 12 months that comes to a net sale of $113.4K. The latest trade was on 04/02.

JS

JS

Jasbir Seehra

CEO

Company

Keros Therapeutics KROS

First filing

23/02/17

Trades

14 trades

Buys / sales

0 / 1

12-month net buying

−$113.4K

Last trade

04/02

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Keros TherapeuticsKROS	Open-market sale	02/19	02/20	7,015 sh	$16.17	$113,432.55	−1.8%